Clinical Trials:
Medical clinical trials plays an important role in development of new drugs. These trials are conducted in three phases.
Introduction
Clinical trials are a means of developing new treatments and medications for diseases and conditions. There are strict rules for clinical trials, which are monitored by the National
Institutes of Health and the U.S Food and Drug Administration. Clinical trials are also called clinical studies, research protocols or medical research and often compare one drug against another to see which is more effective, or the medicine or procedure in a specific demographic
group or for a specific disease.
About Clinical Trials
Why Participate in a Clinical Trial?
Participants in clinical trials can play a more active role in their health care, gain access to new research treatments before they are widely available and help others by contributing to medical research.
Where Do the Ideas for Trials Come from?
Ideas for clinical trials usually come from researchers. After researchers test new therapies or procedures in the laboratory and/or in animal studies, the treatments with the most promising test results are moved into clinical trials. During a trial, more and more information is gained about a new treatment, its risks and how well it may or may not work.
Who Sponsors Clinical Trials?
Clinical trials are sponsored or funded by a variety of organizations or individuals such as physicians, medical institutions,foundations, voluntary medical-related groups and pharmaceutical companies, in addition to federal agencies such as the National Institutes of Health, the Department of Defense and the Department of Veteran’s Affairs. Trials can take place in a variety of locations, such as hospitals, universities, doctors’ offices or community clinics.
What is a Protocol?
A protocol is a study plan on which all clinical trials are based. The plan is carefully designed to safeguard the health of the participants as well as answer specific research questions. A protocol describes what types of people can participate in the trial; the schedule of tests, procedures, medications and dosages; and the length of the study. While in clinical trial, participants following a protocol are seen regularly by the research staff to monitor their health and to determine the safety and effectiveness of their treatment.
What is a Placebo?
A placebo is an inactive pill, liquid, or powder that has no treatment value. In clinical trials, experimental treatments are often compared with placebos to assess the treatment’s effectiveness. In some studies, the participants in the control group will receive a placebo instead of an active drug or treatment.
What is a Control or Control Group?
A control is the standard by which experimental observations are evaluated. In many clinical trials, one group of patients will be given an experimental drug or treatment, while the control group is given either a standard treatment for the illness or a placebo.
What are the Different Types of Clinical Trials?
Treatment trials test new treatments, new combinations of drugs, or new approaches to surgery or radiation therapy. Prevention trials look for better ways to prevent disease in people who have never had the disease or to prevent a disease from returning. These approaches may include medicine, vitamins, vaccines, minerals or lifestyle changes. Screening trials test the best way to detect certain diseases or health conditions. Quality of Life trials (or Supportive Caretrials) explore ways to improve comfort and the equality of life for individuals with a chronic illness.
Classification of Clinical Trials There are three types of clinical trials – phase I, phase II and phase III – each one is designed to learn something different about a new medical treatment.
Phase I Trials
A phase I trial is the first test of a new treatment, and it uses the fewest number of patients (20-30 patients is typical). A phase I trial for a new drug is designed to determine the safety of the new drug, how to best administer it and the correct dosage (i.e., one that will minimize undesirable side effects). Because investigators are very interested in how the drug behaves in the body, patients in a phase I trial undergo frequent monitoring of their vital signs. Although drugs being tested in a phase I trial have shown promise in the laboratory, there is no guarantee that the drug will have any positive effects on a patient. Patients participating in a phase I drug trial help advance basic medical knowledge; they may or may not reap any personal benefits.
Phase II Trials
After a phase I clinical trial has determined the safe dose of a drug, it can enter a phase II trial, which begins the process of determining the drug’s effectiveness in treating a specific type of disease. Because a phase II trial involves more patients than a phase I trial, physicians also have a chance to observe any less common side effects associated with the drug. In a phase II
trial, which can involve 100 patients or more, physicians carefully monitor patients for a drug effect. For example, in a clinical trial testing a drug to increase the number of platelets in the blood, patients would have frequent blood samples taken, but they might also undergo several physical exams and other tests. The high level of patient monitoring in a phase II trial can be very time-consuming, so patients should take this into account when considering a phase II trial.
USFDA guidelines, GMP guidelines, WHO guidelines, Schedule M, FDA, European guidelines cleaning validation, process validation, water system validation, ICH guidelines, GMP audut compliance, equipment qualification, Installation Qualification, Operational Qualification, Performance Qualification, Calibration, Validation Protocol, SOPs etc.
Friday, March 8, 2013
Clinical Trials
Clinical Trials:
Medical clinical trials plays an important role in development of new drugs. These trials are conducted in three phases.
Introduction
Clinical trials are a means of developing new treatments and medications for diseases and conditions. There are strict rules for clinical trials, which are monitored by the National
Institutes of Health and the U.S Food and Drug Administration. Clinical trials are also called clinical studies, research protocols or medical research and often compare one drug against another to see which is more effective, or the medicine or procedure in a specific demographic
group or for a specific disease.
About Clinical Trials
Why Participate in a Clinical Trial?
Participants in clinical trials can play a more active role in their health care, gain access to new research treatments before they are widely available and help others by contributing to medical research.
Where Do the Ideas for Trials Come from?
Ideas for clinical trials usually come from researchers. After researchers test new therapies or procedures in the laboratory and/or in animal studies, the treatments with the most promising test results are moved into clinical trials. During a trial, more and more information is gained about a new treatment, its risks and how well it may or may not work.
Who Sponsors Clinical Trials?
Clinical trials are sponsored or funded by a variety of organizations or individuals such as physicians, medical institutions,foundations, voluntary medical-related groups and pharmaceutical companies, in addition to federal agencies such as the National Institutes of Health, the Department of Defense and the Department of Veteran’s Affairs. Trials can take place in a variety of locations, such as hospitals, universities, doctors’ offices or community clinics.
What is a Protocol?
A protocol is a study plan on which all clinical trials are based. The plan is carefully designed to safeguard the health of the participants as well as answer specific research questions. A protocol describes what types of people can participate in the trial; the schedule of tests, procedures, medications and dosages; and the length of the study. While in clinical trial, participants following a protocol are seen regularly by the research staff to monitor their health and to determine the safety and effectiveness of their treatment.
What is a Placebo?
A placebo is an inactive pill, liquid, or powder that has no treatment value. In clinical trials, experimental treatments are often compared with placebos to assess the treatment’s effectiveness. In some studies, the participants in the control group will receive a placebo instead of an active drug or treatment.
What is a Control or Control Group?
A control is the standard by which experimental observations are evaluated. In many clinical trials, one group of patients will be given an experimental drug or treatment, while the control group is given either a standard treatment for the illness or a placebo.
What are the Different Types of Clinical Trials?
Treatment trials test new treatments, new combinations of drugs, or new approaches to surgery or radiation therapy. Prevention trials look for better ways to prevent disease in people who have never had the disease or to prevent a disease from returning. These approaches may include medicine, vitamins, vaccines, minerals or lifestyle changes. Screening trials test the best way to detect certain diseases or health conditions. Quality of Life trials (or Supportive Caretrials) explore ways to improve comfort and the equality of life for individuals with a chronic illness.
Classification of Clinical Trials There are three types of clinical trials – phase I, phase II and phase III – each one is designed to learn something different about a new medical treatment.
Phase I Trials
A phase I trial is the first test of a new treatment, and it uses the fewest number of patients (20-30 patients is typical). A phase I trial for a new drug is designed to determine the safety of the new drug, how to best administer it and the correct dosage (i.e., one that will minimize undesirable side effects). Because investigators are very interested in how the drug behaves in the body, patients in a phase I trial undergo frequent monitoring of their vital signs. Although drugs being tested in a phase I trial have shown promise in the laboratory, there is no guarantee that the drug will have any positive effects on a patient. Patients participating in a phase I drug trial help advance basic medical knowledge; they may or may not reap any personal benefits.
Phase II Trials
After a phase I clinical trial has determined the safe dose of a drug, it can enter a phase II trial, which begins the process of determining the drug’s effectiveness in treating a specific type of disease. Because a phase II trial involves more patients than a phase I trial, physicians also have a chance to observe any less common side effects associated with the drug. In a phase II
trial, which can involve 100 patients or more, physicians carefully monitor patients for a drug effect. For example, in a clinical trial testing a drug to increase the number of platelets in the blood, patients would have frequent blood samples taken, but they might also undergo several physical exams and other tests. The high level of patient monitoring in a phase II trial can be very time-consuming, so patients should take this into account when considering a phase II trial.
Monday, February 4, 2013
GSF2013
The National Geographic Society is one of the world's largest nonprofit scientific and educational organizations. Founded in 1888 to "increase and diffuse geographic knowledge," the Society's mission is to inspire people to care about the planet. It reaches more than 400 million people worldwide each month through its official journal, National Geographic, and other magazines; National Geographic Channel; television documentaries; music; radio; films; books; DVDs; maps; exhibitions; live events; school publishing programs; interactive media; and merchandise. National Geographic has funded more than 10,000 scientific research, conservation and exploration projects. For more information, visit www.nationalgeographic.com.
As the non-commercial, educational outreach arm of the National Geographic Society, National Geographic Education pursues two primary goals: to bring National Geographic's rich resources for learning to the largest possible audience of educators worldwide; and to catalyze educational change that will bring National Geographic's vision of a geo-literate society to life. National Geographic Education creates compelling resources for teaching and learning, provides educators with transformative learning experiences, and advocates for improved education in geography, the environmental sciences, and the other disciplines that are critical to geo-literacy. Join the 5.5 million annual visitors at NatGeoEd.org to learn more about National Geographic Education and get involved in building a more geo-literate society
&
Scientific American is at the heart of Nature Publishing Group's (NPG's) consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the longest continuously published magazine in the U.S. and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 14 local-language editions around the world, it reaches more than 5 million opinion-leading citizens, public and private sectors influential, educators and scientists. Scientific American won a 2011 National Magazine Award for General Excellence. Other titles include Scientific American MIND in the US and 14 local-language editions worldwide.
Scientific American is committed to promoting science, technology, engineering and mathematics (STEM) education, and to promoting wider engagement among the public and scientists. In September 2010 NPG became a member of Change the Equation, a CEO-led initiative to cultivate widespread literacy in STEM in the U.S., as part of President Obama's "Educate to Innovate" campaign.
In 2011 Scientific American launched several programs in support of the initiative's goals. Bring Science Home, an ongoing weekly program, provides parents and school age children with simple projects that explain basic science principles they can do at home in just a few minutes. In Citizen Science, Scientific American has created an online platform for children and adults to participate in ongoing scientific research conducted by major research institutions. Scientific American, in partnership with The Zooniverse,launched the whale-song project, Whale FM, which enables "citizen scientists" to help marine researchers better understand how killer whales and pilot whales communicate. With the 1,000 Scientists in 1,000 Days program, Scientific American has created a portal where educators can connect with scientists who have agreed to volunteer their time to benefit STEM education, perhaps by volunteering in a classroom or explaining the latest in research. To encourage science-literacy in children, Scientific American launched our popular blog, Budding Scientist, lead by editor Anna Kutchment. Scientific American is also a media sponsor and participant in the biennial USA Science & Engineering Festival.
In 2012, Scientific American launched the annual Science in Action prize, powered by the Google Science Fair. This prize honors a project that could make a practical difference by addressing an environmental, health or resources problem in the lives of a community.
Subscribe to:
Posts (Atom)